Cosmos Health Inc./$COSM
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Cosmos Health Inc.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
- Ticker
- $COSM
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 163
- Headquarters
- Thessaloniki, Greece
- Website
- www.cosmoshealthinc.com
COSM Metrics
BasicAdvanced
$24M
-
-$0.57
4.21
-
Price and volume
Market cap
$24M
Beta
4.21
52-week high
$0.77
52-week low
$0.16
Average daily volume
2.6M
Financial strength
Current ratio
1.052
Quick ratio
0.674
Long term debt to equity
0.168
Total debt to equity
0.773
Interest coverage (TTM)
-4.91%
Profitability
EBITDA (TTM)
-16.787
Gross margin (TTM)
10.27%
Net profit margin (TTM)
-33.08%
Operating margin (TTM)
-24.65%
Revenue per employee (TTM)
$450,000
Management effectiveness
Return on assets (TTM)
-18.42%
Return on equity (TTM)
-104.00%
Valuation
Price to revenue (TTM)
0.139
Price to book
0.92
Price to tangible book (TTM)
1.39
Price to free cash flow (TTM)
-1.028
Free cash flow yield (TTM)
-97.27%
Free cash flow per share (TTM)
-0.23
Growth
Revenue change (TTM)
33.82%
Earnings per share change (TTM)
-35.90%
3-year revenue growth (CAGR)
14.76%
10-year revenue growth (CAGR)
39.58%
3-year earnings per share growth (CAGR)
-54.44%
10-year earnings per share growth (CAGR)
-26.99%
What the Analysts think about COSM
Analyst ratings (Buy, Hold, Sell) for Cosmos Health Inc. stock.
Analyst projections of the future price of Cosmos Health Inc. stock.
COSM Financial Performance
Revenues and expenses
COSM Earnings Performance
Company profitability
Upcoming events
No upcoming events
COSM News
AllArticlesVideos
Cosmos Health Expands E-Commerce and Subscription Business to Australia, New Zealand and the Broader Oceania Region, With Sales Already Underway
Accesswire3 weeks ago
Cosmos Health CEO Greg Siokas Issues Letter to Shareholders Highlighting Record 2026 Revenue, U.S. Subscription Growth and Global Expansion
Accesswire3 weeks ago
Cosmos Health Provides Update on United States Business; Q4 2026 U.S. Revenue Expected to Reach $15 Million, with Gross Profit of $10.5 Million; Active U.S. Subscriptions Up 42% from 6,287 to 8,940 in Just Five Days
Accesswire3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.